A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age

Authors:

Abstract
No abstract available
Funding Information
  • Bill & Melinda Gates Foundation

This publication has 33 references indexed in Scilit: